November 29, 2005
Dr. John Charles, Deputy Chief Scientist for Bioastronautics, Space Life Sciences Directorate, NASA Johnson Space Center, 10/19/05
Dr. John B. Charles is the Deputy Chief Scientist for Bioastronautics in the Space Life Sciences Directorate at NASA’s Johnson Space Center near Houston, TX. He plays a leading role in Bioastronautics activities preparing for human exploration of space beyond low Earth orbit. Dr. Charles's research into the cardiovascular effects of space flight involved him as the principal investigator on experiments that flew on Space Shuttle flights and on the Russian space station Mir. He was the NASA Mission Scientist for the STS-107 multidisciplinary mission on the Shuttle Orbiter Columbia in January 2003.
Most recently, Dr. Charles was the NASA lead for the Bioastronautics Roadmap project, a blueprint for human risk reduction through focused research and technology, benefiting crews on the International Space Station as well as on missions to the Moon and beyond. He has published over 45 scientific articles, and received several scientific and performance awards including NASA’s Exceptional Service Medal and the “Silver Snoopy” astronaut recognition award.
November 17, 2005
Dr. George Bekey, Gordon Marshall Professor of Computer Science, Electrical Engineering and Biomedical Engineering, University of Southern California, 11/16/05
Dr. George A. Bekey is Gordon Marshall Professor of Computer Science, Electrical Engineering and Biomedical Engineering at the University of Southern California. His research interests are in the areas of cooperative intelligent multiple robotic systems and applications of AI and robotics to medicine. Dr. Bekey was a founder of the Biomedical Engineering Department and the founder of the Robotics Research Laboratory at USC.
Dr. Bekey has published over 200 technical papers in the areas of robotics, computer simulation, control systems, biomedical engineering, and human-machine systems. He is the co-author (with W.J. Karplus) of a textbook, Hybrid Computation (Wiley, 1968), and co-editor of several books, the most recent being Neural Networks and Robotics (Kluwer, 1993), Autonomous Underwater Robotic Systems (Kluwer, 1996), and Robot Colonies (Kluwer, 1997). Dr. Bekey is Editor-in-Chief of the journal Autonomous Robots, Founding Editor of the IEEE Transactions on Robotics and Automation, and a member of the editorial boards of Mathematics and Computers in Simulation and Transactions of the Society of Computer Simulation.
November 12, 2005
Dr. Carlo D. Montemagno, Chairman, Department of Bioengineering; Carol and Roy Doumani Professor of Biomedical Engineering; and Professor, Mechanical and Aerospace Engineering, UCLA, 11/9/05
Nanotechnology, hybrid living-nonliving systems, artificial neurons, robust defect-tolerant systems.
Dr. Carlo Montemagno's research is focused on the application of nanotechnology to biological systems. He is well known for having engineered and fabricated the first nanobiomechanical motor system. Dr. Montemagno has published over 60 papers, holds several patents, and has presented over 45 keynote or invited talks at international conferences. For his cumulative work, Dr. Montemagno was awarded the Feynman Prize in Nanotechnology in 2003.
Dr. Montemagno's current research projects are directed at the development of biomolecular motor–powered nanoelectromechanical devices, muscle-powered MEMS devices, microrobotics, and the engineering of on-chip detectors for pathogens. In addition to his academic accomplishments, Dr. Montemagno has provided extensive services to professional societies around the world. He is a member of many national scientific committees, has provided guidance to other governments on the development of NEMS technologies, and chaired or served on numerous organizing committees of international conferences on emerging technology.
November 07, 2005
Dr. Alan P. Zelicoff, author, MICROBE: Are We Ready for the Next Plague?, 11/2/05
Dr. Alan Zelicoff's new book, MICROBE: Are We Ready For the Next Plague?, co-authored by risk management expert Michael Bellomo, provides detailed accounts of the various animal-to-human transmitted viruses, bacteria, and plagues, and provides practical solutions to stop outbreaks and minimize the impact of a health epidemic. The book covers current problems in the nation’s public health infrastructure, bioterrorism, and solutions to address emerging diseases in a timely way so as to permit effective intervention.
Dr. Zelicoff is a physician, physicist, and Senior Scientific Consultant for Ares Corporation, a risk-analysis engineering firm with offices across the U.S. He is the inventor of the Syndrome Reporting Information System, a platform-independent, networked disease monitoring tool for public health officials, physicians, veterinarians, laboratory and EMS professionals, emergency management coordinators, and decision-makers.
November 03, 2005
Dr. Albert Deisseroth, President and CEO, Sidney Kimmel Cancer Center, 11/2/05
Dr. Albert Deisseroth is best known for the development of new directions in the treatment of leukemias and solid tumors through the use of molecular targeting and genetic therapy. Currently he is launching genetic therapy trials for vascular targeting therapy and vaccine therapy of epithelial neoplasms. He is also involved with vector mediated chemotherapy sensitization that is tumor specific, a method designed to decrease toxicity and adverse side effects while at the same time increasing the efficacy of responses produced.
Dr. Deisseroth is the author of nearly 400 articles and reports on cancer research. He has served or currently serves on the editorial boards of Contemporary Oncology, Cancer Research, Somatic Cell and Molecular Genetics, Blood, Cancer, Cancer Research, The Cancer Journal, Clinical Cancer Research, Human Gene Therapy, and Cancer Gene Therapy.
Founded in 1990, the Sidney Kimmel Cancer Center is a nonprofit research institute dedicated to the development of advanced biological cancer treatments, such as gene therapy, angiostatic therapy, vaccine therapy, and immunotherapy, and to making those treatments readily available to patients. The National Cancer Institute ranks SKCC as one of the top three cancer centers in the United States in the application of genomics and proteomics to the treatment of specific cancers.
November 01, 2005
Dr. David Applegate, Senior Science Advisor for Earthquake and Geologic Hazards, U.S. Geological Survey, 8/5/05
Dr. David Applegate leads the Earthquake Hazards, Global Seismographic Network, and Geomagnetism Programs and provides coordination for geologic hazards activities across the U.S. Geological Survey. He also serves as Vice-Chair of the National Science and Technology Council's interagency Subcommittee on Disaster Reduction. In addition to his USGS duties, Dr. Applegate is an adjunct faculty member of the University of Utah's Department of Geology and Geophysics, and an instructor in the Environmental Sciences and Policy master's program at The Johns Hopkins Univesity.
Dr. Applegate received a Presidential Certificate of Merit from the American Institute of Professional Geologists in 2002, and has recently received the Public Service Award from the Geological Society of America (October 2005).
Created by an act of Congress in 1879, the U.S. Geologic Survey has evolved over the ensuing 120 years, matching its talent and knowledge to the progress of science and technology. Today, the USGS stands as the sole science agency for the Department of the Interior. It is sought out by thousands of partners and customers for its natural science expertise and its vast earth and biological data holdings. The USGS is the science provider of choice in accessing the information and understanding to help resolve complex natural resource problems across the Nation and around the world.
The USGS serves as an independent fact-finding agency that collects, monitors, analyzes, and provides scientific understanding about natural resource conditions, issues, and problems. The value of the USGS rests on its ability to carry out studies on a national scale and to sustain long-term monitoring and assessment of natural resources. Because it has no regulatory or management mandate, the USGS provides impartial science that serves the needs of our changing world. The diversity of scientific expertise enables the USGS to carry out large-scale, multidisciplinary investigations that build the base of knowledge about the Earth. In turn, decision makers at all levels of government—and citizens in all walks of life—have the information tools they need to address pressing societal issues.